|
Lipids
Citations 351-360 of 397 total displayed.
|
Past content
(since Feb 1999):
|
- Basic Science Reports
Evidence for Oxidative Activation of c-Myc–Dependent Nuclear Signaling in Human Coronary Smooth Muscle Cells and in Early Lesions of Watanabe Heritable Hyperlipidemic Rabbits : Protective Effects of Vitamin E
- Filomena de Nigris, Tammam Youssef, SilviaAnna Ciafré, Flavia Franconi, Vittorio Anania, GianLuigi Condorelli, Wulf Palinski, and Claudio Napoli
Circulation 2000;102:2111-2117
[Abstract]
[Full text]
- Clinical Investigations and Reports
VLDL, Apolipoproteins B, CIII, and E, and Risk of Recurrent Coronary Events in the Cholesterol and Recurrent Events (CARE) Trial
- Frank M. Sacks, Petar Alaupovic, Lemuel A. Moye, Thomas G. Cole, Bruce Sussex, Meir J. Stampfer, Marc A. Pfeffer, and Eugene Braunwald
Circulation 2000;102:1886-1892
[Abstract]
[Full text]
- Clinical Investigations and Reports
Effect of Pravastatin on Coronary Disease Events in Subgroups Defined by Coronary Risk Factors : The Prospective Pravastatin Pooling Project
- Frank M. Sacks, Andrew M. Tonkin, James Shepherd, Eugene Braunwald, Stuart Cobbe, C. Morton Hawkins, Anthony Keech, Christopher Packard, John Simes, Robert Byington, and Curt D. Furberg
Circulation 2000;102:1893-1900
[Abstract]
[Full text]
- Clinical Investigations and Reports
Long-Term Effects of Cholesterol Lowering and Angiotensin-Converting Enzyme Inhibition on Coronary Atherosclerosis : The Simvastatin/Enalapril Coronary Atherosclerosis Trial (SCAT)
- Koon K. Teo, Jeffrey R. Burton, Christopher E. Buller, Sylvain Plante, Diane Catellier, Wayne Tymchak, Vladimir Dzavik, Dylan Taylor, Shinji Yokoyama, and Terrence J. Montague
Circulation 2000;102:1748-1754
[Abstract]
[Full text]
- Clinical Investigations and Reports
Development of Antibody Against Epitope of Lipoprotein(a) Modified by Oxidation : Evaluation of New Enzyme-Linked Immunosorbent Assay for Oxidized Lipoprotein(a)
- Shingo Yamada, Ryuichi Morishita, Shigefumi Nakamura, Toshio Ogihara, Yoshiaki Kusumi, Isamu Sakurai, Nobuhiko Kubo, and Ikunosuke Sakurabayashi
Circulation 2000;102:1639-1644
[Abstract]
[Full text]
- Correspondence
C-Reactive Protein and Hormone Replacement Therapy • Response
- Naveed Sattar, Nita G. Forouhi, Robert A. Wild, Mary Cushman, Pamela A. Sakkinen, Russell P. Tracy, Claudine Legault, Elizabeth Barrett-Connor, Marcia L. Stefanick, Craig M. Kessler, and Howard L. Judd
Circulation 2000;102:e96-97e
[Full text]
- Clinical Investigations and Reports
Prospective, Randomized, Infancy-Onset Trial of the Effects of a Low-Saturated-Fat, Low-Cholesterol Diet on Serum Lipids and Lipoproteins Before School Age : The Special Turku Coronary Risk Factor Intervention Project (STRIP)
- Leena Rask-Nissilä, Eero Jokinen, Tapani Rönnemaa, Jorma Viikari, Anne Tammi, Harri Niinikoski, Ritva Seppänen, Juhani Tuominen, and Olli Simell
Circulation 2000;102:1477-1483
[Abstract]
[Full text]
- Clinical Investigations and Reports
Plasma Homocysteine Predicts Mortality Independently of Traditional Risk Factors and C-Reactive Protein in Patients With Angiographically Defined Coronary Artery Disease
- Jeffrey L. Anderson, Joseph B. Muhlestein, Benjamin D. Horne, John F. Carlquist, Tami L. Bair, Troy E. Madsen, and Robert R. Pearson
Circulation 2000;102:1227-1232
[Abstract]
[Full text]
- Clinical Investigations and Reports
Red Wine Intake Prevents Nuclear Factor- B Activation in Peripheral Blood Mononuclear Cells of Healthy Volunteers During Postprandial Lipemia
- Luis Miguel Blanco-Colio, Mónica Valderrama, Luis Antonio Alvarez-Sala, Carmen Bustos, Mónica Ortego, Miguel Angel Hernández-Presa, Pilar Cancelas, Juan Gómez-Gerique, Jesús Millán, and Jesús Egido
Circulation 2000;102:1020-1026
[Abstract]
[Full text]
- Clinical Investigations and Reports
Cost-Effectiveness of Treating Hyperlipidemia in the Presence of Diabetes : Who Should Be Treated?
- Steven A. Grover, Louis Coupal, Hanna Zowall, and Marc Dorais
Circulation 2000;102:722-727
[Abstract]
[Full text]
|
|
